Skip to main content
. 2021 Sep 30;349:130739. doi: 10.1016/j.snb.2021.130739

Table 2.

Determination of NP in diluted human serum samples.

Serum Sample Initial (pg/mL) Added (pg/mL) Found (pg/mL) Recovery (%)
Healthy 1* 1 1.04 ± 0.03 103.9
2* 5 4.87 ± 0.22 97.4
3* 10 10.81 ± 0.69 108.1
4* 50 49.25 ± 1.72 98.4
5# 1 1.06 ± 0.06 106.3
6# 5 5.11 ± 0.18 102.3
7# 10 10.94 ± 0.55 109.4
8# 50 52.35 ± 1.26 104.7
COVID-19 Patient 1* 5.15 ± 0.34 10 14.47 ± 0.34 95.5
2* 1.85 ± 0.12 10 12.37 ± 0.44 104.5
3* 27.59 ± 1.42 10 40.07 ± 2.53 106.6
4* 5.28 ± 0.33 10 16.42 ± 0.46 107.5
5# 37.05 ± 0.96 10 42.85 ± 1.34 91.1
6# 129.8 ± 4.04 10 146.5 ± 3.72 104.8

“-”: undetectable

“*”: 100-fold diluted; “#”: 20-fold diluted